Eszopiclone

Product NDC: 0093-5538
Requested package NDC: 0093-5538-01
11-digit product format: 000935538
Labeler code: 0093
Product ID: 0093-5538_359cf2e6-4461-4ebf-a542-06736029d9d0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Eszopiclone
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA091169
Marketing category: ANDA
Marketing start: 2014-04-14
Marketing end: 0000-00-00
Substance: ESZOPICLONE
Active strength: 2 mg/1
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0093-5538	0093-5538-01	D	Discontinued by firm		2026-11-13

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A091169-001	ESZOPICLONE	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23
A091169-002	ESZOPICLONE	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23
A091169-003	ESZOPICLONE	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A091169-001	AB
A091169-002	AB
A091169-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 135 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-11-14 07:37:17	2026-10	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`d4dbc9d85df4…`
2026-10-15 13:18:30	2026-09	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2011-05-23	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2011-05-23	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091169-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2011-05-23	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 135 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-11-14 07:37:17	2026-10	A091169-001	AB	1	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A091169-002	AB	1	`d4dbc9d85df4…`
2026-11-14 07:37:17	2026-10	A091169-003	AB	1	`d4dbc9d85df4…`
2026-10-15 13:18:30	2026-09	A091169-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091169-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A091169-003	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A091169-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091169-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091169-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091169-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091169-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091169-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091169-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091169-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091169-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091169-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091169-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091169-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091169-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091169-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091169-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091169-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091169-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091169-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091169-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091169-001	AB	1	`d06236e962d9…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f65008ed-f925-2246-581a-e6a3201df7e4	Product name	5	20250107
351abe41-466c-4dd8-840a-0fdb68318bd5	Product name	1	20230316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0093-5538-01	Eszopiclone	100 in 1 BOTTLE	TABLET, FILM COATED	100		17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-5538-01	EA - Each	0093-5538	2b45db4b-a511-4f0e-942e-29b7e4dfa57e	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ESZOPICLONE	ACTIVE INGREDIENT	UZX80K71OE	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
ESZOPICLONE	ACTIVE MOIETY	UZX80K71OE	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
HYPROMELLOSE 2910 (3 MPA.S)	INACTIVE INGREDIENT	0VUT3PMY82	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ESZOPICLONE TABLET, FILM COATED [UNIT DOSE SERVICES]	7
ESZOPICLONE	ACTIVE INGREDIENT	UZX80K71OE	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
ESZOPICLONE	ACTIVE MOIETY	UZX80K71OE	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
HYPROMELLOSE 2910 (3 MPA.S)	INACTIVE INGREDIENT	0VUT3PMY82	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
POLYETHYLENE GLYCOL 6000	INACTIVE INGREDIENT	30IQX730WE	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0093-5538	ESZOPICLONE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.]	15	Legacy NDC, 1 package rows	20211102_2435e2f1-bc52-488f-80e9-f1758e354aae.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Eszopiclone	ESZOPICLONE	Teva Pharmaceuticals USA, Inc.	2435e2f1-bc52-488f-80e9-f1758e354aae	2021-08-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091169 application number: ANDA091169 ndc (package): 0093-5538-01 ndc (product): 0093-5538 ndc11 (package): 00093553801
Eszopiclone	ESZOPICLONE	Aphena Pharma Solutions - Tennessee, LLC	9bbf260f-3090-46b5-b3ef-81174697f166	2020-04-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091169 application number: ANDA091169

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UZX80K71OE	ESZOPICLONE	138729-47-2	ESZOPICLONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
485440	eszopiclone 1 MG Oral Tablet	PSN	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485442	eszopiclone 2 MG Oral Tablet	PSN	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485465	eszopiclone 3 MG Oral Tablet	PSN	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485440	eszopiclone 1 MG Oral Tablet	SCD	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485442	eszopiclone 2 MG Oral Tablet	SCD	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485465	eszopiclone 3 MG Oral Tablet	SCD	2435e2f1-bc52-488f-80e9-f1758e354aae	17
485442	eszopiclone 2 MG Oral Tablet	PSN	48925d07-1e06-4761-bbdc-d8b7e70ad155	11
485465	eszopiclone 3 MG Oral Tablet	PSN	48925d07-1e06-4761-bbdc-d8b7e70ad155	11
485442	eszopiclone 2 MG Oral Tablet	SCD	48925d07-1e06-4761-bbdc-d8b7e70ad155	11
485465	eszopiclone 3 MG Oral Tablet	SCD	48925d07-1e06-4761-bbdc-d8b7e70ad155	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0093-5538-01	00093553801	100 TABLET, FILM COATED in 1 BOTTLE (0093-5538-01)	2014-04-14	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Eszopiclone	Teva Pharmaceuticals USA, Inc.	2021-08-01	HUMAN PRESCRIPTION DRUG LABEL	17
Eszopiclone	Unit Dose Services	2017-06-15	HUMAN PRESCRIPTION DRUG LABEL	11